RNA‐Cleaving DNAzyme‐Based Amplification Strategies for Biosensing and Therapy
Advanced Healthcare Materials · 2023-09 · 12 (23)
DOI: 10.1002/adhm.202300367 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, online erschienen am 12.05.2023. Verfasst von Jiaxin Su und 5 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory for Bioengineering and Sensing Technology, School of Chemistry & Biological Engineering, University of Science & Technology Be…. Hauptthemen laut MEDLINE: DNA, Catalytic, Biosensing Techniques. Die Arbeit wurde bisher 75-mal zitiert (Crossref) und nennt 183 Literaturangaben.
Abstract (Originalsprache)
Since their first discovery in 1994, DNAzymes have been extensively applied in biosensing and therapy that act as recognition elements and signal generators with the outstanding properties of good stability, simple synthesis, and high sensitivity. One subset, RNA‐cleaving DNAzymes, is widely employed for diverse applications, including as reporters capable of transmitting detectable signals. In this review, the recent advances of RNA‐cleaving DNAzyme‐based amplification strategies in scaled‐up biosensing are focused, the application in diagnosis and disease treatment are also discussed. Two major types of RNA‐cleaving DNAzyme‐based amplification strategies are highlighted, namely direct response amplification strategies and combinational response amplification strategies. The direct response amplification strategies refer to those based on novel designed single‐stranded DNAzyme, and the combinational response amplification strategies mainly include two‐part assembled DNAzyme, cascade reactions, CHA/HCR/RCA, DNA walker, CRISPR‐Cas12a and aptamer. Finally, the current status of DNAzymes, the challenges, and the prospects of DNAzyme‐based biosensors are presented.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing Key Laboratory for Bioengineering and Sensing Technology, School of Chemistry & Biological Engineering, University of Science & Technology Beijing, 30 Xueyuan Road, Beijing, 100083, China.
- Marshall Laboratory of Biomedical Engineering, Shenzhen Key Laboratory for Nano-Biosensing Technology, School of Biomedical Engineering, Shenzhen University Medical School, Shenzhen University, Shenzhen, Guangdong, 5180…
- Guangdong Laboratory of Artificial Intelligence and Digital Economy (SZ), Shenzhen, Guangdong, 518060, P. R. China.
ORCID-Profile: Haifeng Dong
Zitieren
APA
Su, J., Sun, C., Du, J., Xing, X., Wang, F., & Dong, H. (2023). RNA‐Cleaving DNAzyme‐Based Amplification Strategies for Biosensing and Therapy. Advanced Healthcare Materials, 12(23). https://doi.org/10.1002/adhm.202300367
Vancouver
Su J, Sun C, Du J, Xing X, Wang F, Dong H. RNA‐Cleaving DNAzyme‐Based Amplification Strategies for Biosensing and Therapy. Advanced Healthcare Materials. 2023;12(23). doi:10.1002/adhm.202300367
BibTeX
@article{Su2023,
author = {Su, Jiaxin and Sun, Chenyang and Du, Jinya and Xing, Xiaotong and Wang, Fang and Dong, Haifeng},
title = {RNA‐Cleaving DNAzyme‐Based Amplification Strategies for Biosensing and Therapy},
journal = {Advanced Healthcare Materials},
year = {2023},
volume = {12},
number = {23},
doi = {10.1002/adhm.202300367}
}
EUVIMED